Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, has announced it will release its financial results for the third quarter of 2024 after the market close on Wednesday, November 6th, 2024. The company management will host a conference call to discuss the financial results at 5:00PM ET. Investors interested in participating in the conference call are required to register online, with registration recommended at least one day in advance. A live and archived webcast of the event will be available on the "Investors" section of Certara's website at https://ir.certara.com/.
Certara, Inc. (Nasdaq: CERT), un leader globale nello sviluppo di farmaci informato dai modelli, ha annunciato che rilascerà i suoi risultati finanziari per il terzo trimestre del 2024 dopo la chiusura del mercato di mercoledì 6 novembre 2024. Il management dell'azienda ospiterà una chiamata di conferenza per discutere i risultati finanziari alle 17:00 ET. Gli investitori interessati a partecipare alla chiamata devono registrarsi online, con registrazione raccomandata almeno un giorno prima. Un webcast dal vivo e archiviato dell'evento sarà disponibile nella sezione
Certara, Inc. (Nasdaq: CERT), un líder global en el desarrollo de medicamentos informado por modelos, ha anunciado que publicará sus resultados financieros para el tercer trimestre de 2024 después del cierre del mercado el miércoles 6 de noviembre de 2024. La dirección de la empresa llevará a cabo una llamada de conferencia para discutir los resultados financieros a las 5:00 PM ET. Los inversores interesados en participar en la llamada de conferencia deben registrarse en línea, siendo recomendable hacerlo al menos un día antes. Un webcast en vivo y archivado del evento estará disponible en la sección
Certara, Inc. (Nasdaq: CERT), 모델 기반 약물 개발의 세계적 리더,가 2024년 3분기 재무 결과를 2024년 11월 6일 수요일에 장 종료 후 발표할 것이라고 발표했습니다. 회사 경영진은 오후 5시(ET)에 재무 결과를 논의하기 위한 컨퍼런스 콜을 개최합니다. 컨퍼런스 콜에 참여하고자 하는 투자자는 온라인으로 등록해야 하며, 최소 하루 전에 등록하는 것이 권장됩니다. 행사에 대한 실시간 및 기록된 웹캐스트는 Certara 웹사이트의
Certara, Inc. (Nasdaq: CERT), un leader mondial dans le développement de médicaments informé par des modèles, a annoncé qu'il publiera ses résultats financiers pour le troisième trimestre de 2024 après la clôture du marché le mercredi 6 novembre 2024. La direction de l'entreprise organisera une conférence téléphonique pour discuter des résultats financiers à 17h00 ET. Les investisseurs intéressés à participer à la conférence téléphonique doivent s'inscrire en ligne, une inscription au moins un jour à l'avance étant recommandée. Un webinaire en direct et archivé de l'événement sera disponible dans la section
Certara, Inc. (Nasdaq: CERT), ein globaler Marktführer in der modellgestützten Arzneimittelentwicklung, hat bekannt gegeben, dass es seine Finanzergebnisse für das dritte Quartal 2024 nach Börsenschluss am Mittwoch, den 6. November 2024 veröffentlichen wird. Das Management des Unternehmens wird um 17:00 Uhr ET eine Telefonkonferenz abhalten, um die Finanzergebnisse zu diskutieren. Investoren, die an der Telefonkonferenz teilnehmen möchten, müssen sich online registrieren, wobei eine Registrierung mindestens einen Tag im Voraus empfohlen wird. Ein Live- und archivierter Webcast der Veranstaltung wird im Bereich
- None.
- None.
RADNOR, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the third quarter of 2024 after the market close on Wednesday, November 6th, 2024. Company management will host a conference call to discuss financial results at 5:00PM ET.
Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.
A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/.
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com
FAQ
When will Certara (CERT) release its Q3 2024 financial results?
What time is Certara's (CERT) Q3 2024 earnings conference call?
How can investors participate in Certara's (CERT) Q3 2024 earnings call?
Where can I find the webcast of Certara's (CERT) Q3 2024 earnings call?
